Investing for tomorrow

Discover our funds

  • 155bn€

    Assets under management as at 31 December 2024

  • 25

    years of ESG experience

You are browsing from United Kingdom! Would you like to change your location?
Equities, Healthcare, Servaas Michielssens, Linden Thomson

Biotech : 25 years of innovation in the service of healthcare

Over the past twenty-five years, the medical biotechnology sector has profoundly transformed the therapeutic landscape. From the fight against cancer to the development of Covid-19 vaccines in record time, advances in biopharma have changed the outcome for millions of patients worldwide.
CSR Report 2023
Weekly Views
What's next

Latest Insights

  • Research Paper, Alternative Investments, Pieter-Jan Inghelbrecht, Johann Mauchand, Steeve Brument

    Restoring Diversification

    We have previously examined the equity/bond allocation and asked, ‘Is 40/30/30 the new 60/40?’ Well, yes, we think it is. Our work shows a long-term correlation between equities and fixed income that is frighteningly close to 1.0. This increased correlation fundamentally alters the effectiveness of traditional portfolio construction.
  • Ken Van Weyenberg, Equities

    Reshoring: A Catalyst for Smart Manufacturing

    Global manufacturers are navigating a highly challenging environment marked by tariffs, trade conflicts and new alliances, supply chain disruptions, and rising geopolitical tensions.
  • US elections, Asset Allocation, Macro, Florence Pisani, Emile Gagna, Lauren Goodwin

    Trump’s Economic Policy

    The election of Donald Trump, coupled with the Republican Party's control of both houses of Congress, has resulted in a new political landscape in the United States. What key decisions must the new administration make? What impact will these decisions have on the macroeconomic environment, financial markets and investors?
  • Fixed Income, Sylvain De Bus, Philippe Dehoux

    Bonds are Back…So Which Ones?

    European yields have returned to more historical norms following the years in the low-yield wilderness, while the German fiscal situation is reaching an inflection point.
Insights
“At Candriam, we embrace Conviction and Responsibility in everything we do.”
Vincent Hamelink, CEO

Expertise

Thematic

Find it fast

Get information faster with a single click

Get insights straight to your inbox